Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. (Q46493820)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2005

edit

Language	Label	Description	Also known as
English	Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man.	scientific article published on 12 May 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

title

Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

main subject

neuropsychology

1 reference

based on heuristic

inferred from title

consciousness

1 reference

based on heuristic

inferred from title

author name string

Torsten Passie

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

Matthias Karst

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

Birgitt Wiese

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

Hinderk M Emrich

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

Udo Schneider

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

publication date

12 May 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

published in

Neuropsychobiology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

volume

51

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

page(s)

226-233

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

cites work

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

The effects of a sub-anaesthetic dose of ketamine on human selective attention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1159%2F000085724

retrieved

21 January 2018

Identifiers

DOI

10.1159/000085724

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

PubMed publication ID

15897673

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15897673

retrieved

22 December 2017

reference URL

http://europepmc.org/abstract/MED/15897673

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46493820&oldid=1232465192"